Abstract
The current literature results on genetic control of sex differentiation and morphogenesis of the human reproductive system are reviewed. Several examples of the nosologic forms caused by mutations in the genes analyzed are considered.
Similar content being viewed by others
REFERENCES
Swain, A. and Lovell-Badge, R., Mammalian Sex Determination: A Molecular Drama, Genes Dev., 1999, vol. 13, pp. 755-767.
Osipova, G.R., Genetics of Normal and Disturbed Sex Determination, Genetika (Moscow), 1996, vol. 32, no. 2, pp. 184-191.
Vasil'chenko, G.S., Seksopatologiya. Spravochnik (A Handbook on Sexopathology), Moscow: Meditsyna, 1990.
Falin, L.I., Embriologiya cheloveka. Atlas (Human Embryology: An Atlas), Moscow: Meditsyna, 1976.
Van Wagenen, G. and Simpson, M.E., Embryology of the Ovary and Testis in Homo sapiens and Macaca mulatta, New Haven: Yale Univ. Press, 1965.
Semenova-Tyan-Shanskaya, A.G., The Origin, Differentiation, and Migration of Gonocytes in Human Early Embryos, Abstract of Cand. Sci. (Biol.) Dissertation, Leningrad: Institute of Experimental Medicine, Russian Academy of Medical Sciences, 1973.
Kurilo, L.F., Morpho-Functional Characterization of Oogenesis in Mammals and Man, Doctoral (Biol.) Dissertation, Moscow: Kol'tsov Institute of Developmental Biology, 1985.
Bodemer, Ch.W., Modern Embryology, New York: Holt, Rinehart, and Winston, 1968.
England, M.A., A Colour Atlas of Life Before Birth: Normal Fetal Development, London: Wolfe Med., 1983.
Vorsanova, S.G., Yurov, Yu.B., and Chernyshov, V.N., Khromosomnye sindromy i anomalii. Klassifikatsiya i nomenklatura (Chromosome Syndromes and Abnormalities: Classification and Nomenclature), Rostov-on-Don, 1999.
Kozlova, S.I., Demikova, N.S., Semanova, E., and Blinnikova, O.E., Nasledstvennye sindromy i mediko-geneticheskoe konsul'tirovanie (Hereditary Syndromes and Medical Genetic Counseling), Moscow: Praktika, 1996.
Kurilo, L.F., Genetically Determined Disorders of the Male Reproductive System, Seksologiya i andrologiya, Kiev, 1996, issue 3, pp. 28-43.
Kurilo, L.F., A Contribution of Genetic Pathology to Misdevelopment of the Reproductive System in Patients, Seksologiya i andrologiya, Kiev, 1998, issue 4, pp. 18-27.
Page, D.C., Mosher, R., Simpson, E.M., et al., The Sex-Determining Region of the Human Y Chromosome Encodes a Finger Protein, Cell (Cambridge, Mass.), 1987, vol. 51, pp. 1091-1104.
Sinclair, A.H., Berta, P., Palmer, M.S., et al., A Gene from the Human Sex-Determining Region Encodes a Protein with Homology to a Conserved DNA-Binding Motif, Nature, 1990, vol. 346, pp. 240-244.
Cameron, F. and Sinclair, A.H., Mutation in SRY and SOX9: Testis-Determining Genes, Hum. Mutat., 1997, vol. 9, pp. 388-395.
Giese, K., Cox, J., and Grosschedl, R., The HMG Domain of Lymphoid Enhancer Factor 1 Bends DNA and Facilitates Assembly of Functional Nucleoprotein Structures, Cell (Cambridge, Mass.), 1992, vol. 69, pp. 185-195.
McElreavey, K., Vilain, E., Abbas, N., et al., A Regulatory Cascade Hypothesis for Mammalian Sex Determination: SRY Represses a Negative Regulator of Male Development, Proc. Natl. Acad. Sci. USA, 1993, vol. 90, pp. 3368-3372.
McElreavey, K. and Fellous, M., Sex Determination and the Y Chromosome, Am. J. Med. Genet., 1999, vol. 89, pp. 176-185.
Ferrari, S., Harley, V.R., Pontiggia, A., et al., SRY, Like HMG1, Recognizes Sharp Angles in DNA, EMBO J., 1992, vol. 11, pp. 4497-4506.
Harley, V.R., Lovell-Badge, R., and Goodfellow, P.N., Definition of a Consensus DNA-Binding Site for SRY, Nucleic Acids Res., 1994, vol. 22, pp. 1500-1501.
Koopman, P., Gubbay, J., Vivian, N., et al., Male Development of Chromosomally Female Mice Transgenic for sry, Nature, 1991, vol. 351, pp. 117-121.
Hacker, A., Capel, B., Goodfellow, P., and Lovell-Badge, R., Expression of Sry, the Mouse Sex-Determining Gene, Development (Cambridge, UK), 1995, vol. 121, pp. 1603-1614.
Salas-Cortes, L., Jaubert, F., Barbaux, S., et al., The Human SRY Protein Is Present in Fetal and Adult Sertoli Cells and Germ Cells, Int. J. Dev. Biol., 1999, vol. 43, pp. 135-140.
Haqq, C.M., King, C.-Y., Ukiyama, E., et al., Molecular Basis of Mammalian Sexual Determination: Activation of Mullerian Inhibiting Substance Gene Expression by SRY, Science, 1994, vol. 266, pp. 1494-1500.
Pringle, M.J. and Page, D.C., Somatic and Germ Cell Sex Determination in the Developing Gonad, Infertility in the Male, Lipshultz, L.I. and Howards, S.S., Eds., St Louis: Mosby-Year Book, 1997, 3rd ed., pp. 3-22.
MacLean, H.E., Warne, G.L., and Zajac, J.D., Intersex Disorders: Shedding Light on Male Sexual Differentiation beyond SRY, Clin. Endocrinol., 1997, vol. 46, pp. 101-108.
Andrology: Male Reproductive Health and Dysfunction, Nieschlag, E. and Behre, H., Eds., Berlin: Springer-Verlag, 1997, pp. 133-159.
Cooper, C.S. and Sandlow, J.L., Azoospermia in a 46,XX/47,XXX Phenotypic Male, Urology, 1996, vol. 48, pp. 947-948.
Zanaria, E., Muscatelli, F., Bardoni, B., et al., An Unusual Member of the Nuclear Hormone Receptor Superfamily Responsible for X-Linked Adrenal Hypoplasia Congenital, Nature, 1994, vol. 372, pp. 635-641.
Bardoni, B., Zanaria, E., Guioli, S., et al., A Dosage-Sensitive Locus at Chromosome Xp21 Is Involved in Male to Female Sex Reversal, Nat. Genet., 1994, vol. 7, pp. 497-501.
Muscatelli, F., Strom, T.M., Walker, A.P., et al., Mutations in the DAX-1 Gene Rise to Both X-Linked Adrenal Hypoplasia Congenita and Hypogonadotropic Hypospadism, Nature, 1994, vol. 372, pp. 672-676.
Yanase, T., Takayanagi, R., Oba, K., et al., New Mutation of DAX-1 Genes in Two Japanese Patients with XLinked Congenital Adrenal Hypoplasia and Hypogonadotropic Hypogonadism, J. Clin. Endocrinol. Metab., 1996, vol. 81, pp. 166-176.
Swain, A., Narvaez, V., Burgoyne, P., et al., Dax1 Antagonizes Sry Action in Mammalian Sex Determination, Nature, 1998, vol. 391, pp. 761-767.
Habiby, R.L., Boepple, P., Nachtigall, L., et al., Adrenal Hypoplasia Congenital with Hypogonadotropic Hypogonadism, J. Clin. Invest., 1996, vol. 98, pp. 1055-1062.
Lalli, E., Bardoni, B., Zapopoulos, F., et al., A Transcriptional Silencing Domain in DAX-1 Whose Mutation Causes Adrenal Hypoplasia Congenita, Mol. Endocrinol., 1997, vol. 11, pp. 1950-1960.
Kletter, G.B., Gorski, J.L., and Kelch, R.P., Congenital Adrenal Hypoplasia and Isolated Gonadotropin Deficiency, Trends Endocrinol. Metab., 1991, vol. 2, pp. 123-128.
Pritchard-Jones, K., Fleming, S., Davidson, D., et al., The Candidate Wilm's Tumor Gene Is Involved in Genitourinary Development, Nature, 1990, vol. 346, pp. 194-197.
Mueller, R.F., The Denys-Drash Syndrome, J. Med. Genet., 1994, vol. 31, pp. 471-477.
Pelletier, J., Bruening, W., Kashtan, C.E., et al., Germline Mutations in the Wilm's Tumor Suppressor Gene Are Associated with Abnormal Urogenital Development in Denys-Drash Syndrome, Cell (Cambridge, Mass.), 1991, vol. 67, pp. 437-447.
Nachtigal, M.W., Hirokawa, Y., Enyeart-VanHouten, D.L., et al., Wilm's Tumor 1 and Dax-1 Modulate the Orphan Nuclear Receptor SF-1 in Sex-Specific Gene Expression, Cell (Cambridge, Mass.), 1998, vol. 93, pp. 445-454.
Kim, J., Prawitt, D., Bardeesy, N., et al., The Wilm's Tumor Suppressor Gene (Wt1) Product Regulates Dax-1 Gene Expression during Gonadal Differentiation, Mol. Cell. Biol., 1999, vol. 19, pp. 2289-2299.
Nakagama, H., Heinrich, G., Pelletier, J., and Housman, D.E., Sequence and Structural Requirements for High-Affinity DNA-Binding by the WT1 Gene Product, Mol. Cell. Biol., 1995, vol. 15, pp. 1489-1498.
Lee, S.B., Huang, K., Palmer, R., et al., The Wilm's Tumor Suppressor WT1 Encodes a Transcriptional Activator of Amphiregulin, Cell (Cambridge, Mass.), 1999, vol. 98, pp. 663-673.
Kreidberg, J.A., Sariola, H., Loring, J.M., et al., WT-1 Is Required for Early Kidney Development, Cell (Cambridge, Mass.), 1993, vol. 74, pp. 679-691.
Clemens, J.W., Lala, D.S., Parker, K.L., and Richards, J.S., Steroidogenic Factor-1 Binding and Transcriptional Activity of the Cholesterol Side-Chain Cleavage Promoter in Rat Granulosa Cells, Endocrinology, 1994, vol. 134, pp. 1499-1508.
Bakke, M. and Lund, J., Mutually Exclusive Interactions of Two Nuclear Orphan Receptors Determine Activity of a Cyclic Adenosine 3',5'-Monophosphate-Responsive Sequence in the Bovine CYP17 Gene, Mol. Endocrinol., 1995, vol. 9, pp. 327-339.
Ikeda, Y., Shen, W.H., Ingraham, H.A., and Parker, J.L., Developmental Expression of Mouse Steroidogenic Factor-1, an Essential Regulator of the Steroid Hydroxylases, Mol. Endocrinol., 1994, vol. 8, pp. 654-662.
Luo, X., Ikeda, Y., and Parker, K.L., A Cell-Specific Nuclear Receptor Is Essential for Adrenal and Gonadal Development and Sexual Differentiation, Cell (Cambridge, Mass.), 1994, vol. 77, pp. 481-490.
Shen, W.H., Moore, C.C., Ikeda, Y., et al., Nuclear Receptor Steroidogenic Factor 1 Regulates the Mullerian Inhibiting Substance Gene: A Link to the Sex Determination Cascade, Cell (Cambridge, Mass.), 1994, vol. 77, pp. 651-661.
Kent, J., Wheatley, S.C., Andrews, J.E., et al., A Male-Specific Role for SOX-9 in Vertebrate Sex Determination, Development (Cambridge, UK), 1996, vol. 122, pp. 2813-2822.
Meyer, J., Sudbeck, P., Held, M., et al., Mutational Analysis of the SOX9 Gene in Campomelic Dysplasia and Autosomal Sex Reversal: Lack of Genotype/Phenotype Correlations, Hum. Mol. Genet., 1997, vol. 6, pp. 91-98.
Wagner, T., Wirth, J., Meyer, J., et al., Autosomal Sex Reversal and Campomelic Dysplasia Are Caused by Mutations in and around the SRY-Related Gene SOX9, Cell (Cambridge, Mass.), 1994, vol. 79, pp. 1111-1120.
Josso, N., Lamarre, I., Picard, J.Y., et al., Anti-Mullerian Hormone in Early Human Development, Early Hum. Dev., 1993, vol. 33, pp. 91-99.
Faure, E., Gouerdard, L., Imbeaud, S., et al., Mutant Isoforms of the Anti-Mullerian Hormone Type II Receptor Are Not Expressed at the Cell Membrane, J. Biol. Chem., 1996, vol. 271, pp. 30 571-30 575.
Cohen-Haguenauer, O., Picard, J.Y., Mattei, M.-G., et al., Mapping of the Gene for Anti-Mullerian Hormone to the Short Arm of the Human Chromosome 19, Cytogenet. Cell Genet., 1987, vol. 44, pp. 2-6.
Behringer, R.R., Finegold, M.J., and Cate, R.L., Mullerian-Inhibiting Substance Function during Mammalian Sexual Development, Cell (Cambridge, Mass.), 1994, vol. 79, pp. 415-425.
Mishina, Y., Rey, R., Finegold, M.J., et al., Genetic Analysis of the Mullerian-Inhibiting Substance Signal Transduction Pathway in Mammalian Sexual Differentiation, Genes Dev., 1996, vol. 10, pp. 2577-2587.
Viger, R.S., Mertineit, C., Trasler, J.M., and Nemer, M., Transcription Factor GATA-4 Is Expressed in a Sexually Dimorphic Pattern during Mouse Gonadal Development and Is a Potent Activator of the Mullerian-Inhibiting Substance Promoter, Development (Cambridge, UK), 1998, vol. 125, pp. 2665-2675.
De Santa, P., Bonneaud, N., Boizet, B., et al., Direct Interaction of SRY-Related Protein SOX9 and Steroidogenic Factor 1 Regulates Transcription of the Human Anti-Mullerian Hormone Gene, Mol. Cell Biol., 1998, vol. 18, pp. 6653-6665.
Tremblay, J.J. and Viger, R.S., Transcriptional Factor GATA-4 Enhances Mullerian-Inhibiting Substance Gene through a Direct Interaction with SF-1, Mol. Endocrinol., 1999, vol. 13, pp. 1388-1401.
Fujii, T., Pichel, J.G., Taira, M., et al., Expression Patterns of the Murine LIM Class Homeobox Gene lim1 in the Developing Brain and Excretory System, Dev. Dyn., 1994, vol. 199, pp. 73-83.
Torres, M., Gomes-Pardo, E., Dressler, G.R., and Gruss, P., Pax-2 Controls Multiple Steps of Urogenital Development, Development (Cambridge, UK), 1995, vol. 12, pp. 4057-4065.
Bidgood, M.J., Shen, L., and McMahon, A.P., Sertoli Cell Signaling by Desert Hedgehog Regulates the Male Germ Line, Curr. Biol., 1996, vol. 6, pp. 298-304.
Vainio, S., Heikkila, M., Kispert, A., et al., Female Development in Mammals Is Regulated by Wnt-4 Signaling, Nature, 1999, vol. 397, pp. 405-500.
Slavotinek, A., Schwarz, C., Getty, J.F., et al., Two Cases with Interstitial Deletions of Chromosome 2 and Sex Reversal in One, Am. J. Med. Genet., 1999, vol. 86, pp. 75-81.
Bennett, C.P., Docherty, Z., Robb, S.A., et al., Deletion 9p and Sex Reversal, J. Med. Genet., 1993, vol. 30, pp. 518-520.
Veitia, R., Nunes, M., Rapport, R., et al., Swyers Syndrome and 46,XY Partial Gonadal Dysgenesis Associated with 9p Deletions and Absence of Monosomy 9p Syndrome, Am. J. Hum. Genet., 1998, vol. 63, pp. 901-904.
Wilkie, A.O., Campbell, F.M., Daubeney, P., et al., Complete and Partial XY Sex Reversal Associated with Terminal Deletion of 10q: Report of 2 Cases and Literature Review, Am. J. Med. Genet., 1993, vol. 46, pp. 597-600.
Waggoner, D.J., Chow, C.K., Dowton, S.B., and Watson, M.S., Partial Monosomy of Distal 10q: Three New Cases and a Review, Am. J. Med. Genet., 1999, vol. 86, pp. 1-5.
Smith, G.A., McClive, P.J., Western, P.S., et al., Conservation of a Sex-Determining Gene, Nature, 1999, vol. 402, pp. 601-602.
Chillon, M., Casals, T., Mercier, B., et al., Mutations in the Cystic Fibrosis Gene in the Patients with Congenital Absence of the Vas Deferens, N. Engl. J. Med., 1995, vol. 332, pp. 1475-1480.
Kolchanov, N.A., Anan'ko, E.A., Kolpakov, F.A., et al., Gene Networks, Mol. Biol. (Moscow), 2000, vol. 34, no. 4, pp. 533-544.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Chernykh, V.B., Kurilo, L.F. Genetic Control of Sexual Differentiation in Humans. Russian Journal of Genetics 37, 1103–1114 (2001). https://doi.org/10.1023/A:1012390418656
Issue Date:
DOI: https://doi.org/10.1023/A:1012390418656